Evidence map›Paper›PMID 31649508›Full record

ArticleFrontiers in cellular neuroscience2019

Loss of IL-10 Promotes Differentiation of Microglia to a M1 Phenotype.

Björn Laffer, Dirk Bauer, Susanne Wasmuth, Martin Busch, Tida Viola Jalilvand, Solon Thanos, Gerd Meyer Zu Hörste, Karin Loser, Thomas Langmann, Arnd Heiligenhaus and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 106 citations in OpenAlex.

  1. Article
  2. Review
  3. Synthetic Cyclic CAntioxidants (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Activation of Hippocampal ACE2 Prevents the Dysbiosis-induced Depression-like Behavior in Mice by Enhanced Neurogenesis and Neuroprotection via Mas Receptor.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Björn LafferDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.
Dirk BauerDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.
Susanne WasmuthDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.
Martin BuschDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.
Tida Viola JalilvandDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.
Solon ThanosDepartment of Experimental Ophthalmology, Westphalian Wilhelms University of Münster, Münster, Germany.
Gerd Meyer Zu HörsteDepartment of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Karin LoserDepartment of Dermatology - Experimental Dermatology and Immunobiology of the Skin, University of Münster, Münster, Germany.
Thomas LangmannLaboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
Arnd HeiligenhausDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.
Maren KasperDepartment of Ophthalmology and Ophtha-Lab at St. Franziskus-Hospital, Münster, Germany.
St. Franziskus Hospital · DEUniversity of Duisburg-Essen · DEUniversity of Münster · DEUniversity Hospital Cologne · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microglia represent the primary resident immune cells of the central nervous system (CNS) and modulate local immune responses. Depending on their physiological functions, microglia can be classified into pro- (M1) and anti-inflammatory (M2) phenotype. Interleukin (IL)-10 is an important modulator of neuronal homeostasis, with anti-inflammatory and neuroprotective functions, and can be released by microglia. Here, we investigated how IL-10 deficiency affected the M1/2 polarization of primary microglia upon lipopolysaccharide (LPS) stimulation

Indexed as

cytokinesinterleukin-10lipopolysaccharideM1/2 polarizationmicrogliaphenotype

Identifiers

PMID31649508
PMCPMC6794388
OpenAlexW2979963107

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.